|
JPS5742852A
(en)
*
|
1980-08-27 |
1982-03-10 |
Seikagaku Kogyo Co Ltd |
Erythrocyte sensitized with antibody of polysaccharide of hemolytic streptococcus
|
|
US5156840A
(en)
|
1982-03-09 |
1992-10-20 |
Cytogen Corporation |
Amine-containing porphyrin derivatives
|
|
US4867973A
(en)
|
1984-08-31 |
1989-09-19 |
Cytogen Corporation |
Antibody-therapeutic agent conjugates
|
|
US4671958A
(en)
|
1982-03-09 |
1987-06-09 |
Cytogen Corporation |
Antibody conjugates for the delivery of compounds to target sites
|
|
US5140104A
(en)
|
1982-03-09 |
1992-08-18 |
Cytogen Corporation |
Amine derivatives of folic acid analogs
|
|
US4950738A
(en)
|
1984-09-13 |
1990-08-21 |
Cytogen Corporation |
Amine derivatives of anthracycline antibiotics
|
|
CA1203164A
(en)
|
1982-03-09 |
1986-04-15 |
Thomas J. Mckearn |
Antibody conjugates
|
|
US5162512A
(en)
|
1982-03-09 |
1992-11-10 |
Cytogen Corporation |
Amine derivatives of anthracycline antibodies
|
|
US4741900A
(en)
|
1982-11-16 |
1988-05-03 |
Cytogen Corporation |
Antibody-metal ion complexes
|
|
SU1163864A1
(ru)
*
|
1983-01-19 |
1985-06-30 |
Ордена Ленина Институт Химической Физики Ан Ссср |
Способ определени антиэритроцитарных антител
|
|
EP0119650A3
(en)
|
1983-03-21 |
1987-09-30 |
THE PROCTER & GAMBLE COMPANY |
Galactosyl-insulin conjugates useful in treating diabetics
|
|
JPS59173762A
(ja)
*
|
1983-03-22 |
1984-10-01 |
Green Cross Corp:The |
逆受身抗体赤血球凝集反応用試薬
|
|
CA1260827A
(en)
|
1984-08-31 |
1989-09-26 |
Richard C. Siegel |
Antibody-metal ion complexes
|
|
AU583854B2
(en)
|
1984-09-13 |
1989-05-11 |
Cytogen Corporation |
Antibody therapeutic agent conjugates
|
|
CA1330378C
(en)
|
1986-05-08 |
1994-06-21 |
Daniel J. Coughlin |
Amine derivatives of folic acid analogs
|
|
US5086002A
(en)
*
|
1987-09-07 |
1992-02-04 |
Agen Biomedical, Ltd. |
Erythrocyte agglutination assay
|
|
US20030022826A1
(en)
|
1987-09-08 |
2003-01-30 |
Duke University |
Use of synthetic peptides to induce tolerance to pathogenic T and B cell epitopes of autoantigens or infectious agents
|
|
US4859449A
(en)
|
1987-09-14 |
1989-08-22 |
Center For Molecular Medicine And Immunology |
Modified antibodies for enhanced hepatocyte clearance
|
|
IL87768A
(en)
*
|
1987-09-17 |
1994-12-29 |
Agen Ltd |
Blood assay including erythrocyte agglutination and reagent for the assay comprising conjugate of erythrocyte binding molecule and analyte binding molecule
|
|
US5358857A
(en)
|
1989-08-29 |
1994-10-25 |
The General Hospital Corp. |
Method of preparing fusion proteins
|
|
US5227293A
(en)
|
1989-08-29 |
1993-07-13 |
The General Hospital Corporation |
Fusion proteins, their preparation and use
|
|
US5227165A
(en)
|
1989-11-13 |
1993-07-13 |
Nova Pharmaceutical Corporation |
Liposphere delivery systems for local anesthetics
|
|
WO1991008770A1
(en)
|
1989-12-11 |
1991-06-27 |
Immunomedics, Inc. |
Method for antibody targeting of diagnostic or therapeutic agents
|
|
JPH0436185A
(ja)
|
1990-03-28 |
1992-02-06 |
Kyowa Hakko Kogyo Co Ltd |
融合抗原ポリペプチド
|
|
AU8869291A
(en)
|
1990-10-04 |
1992-04-28 |
University Of Virginia Alumni Patents Foundation, The |
Primate erythrocyte bound monoclonal antibody heteropolymers
|
|
KR950014915B1
(ko)
|
1991-06-19 |
1995-12-18 |
주식회사녹십자 |
탈시알로당단백-포함화합물
|
|
EP0630407B1
(en)
|
1992-03-11 |
2000-08-02 |
PRENDERGAST, Kenneth, Francis |
Anti-viral fusion peptides
|
|
GB9219562D0
(en)
*
|
1992-03-11 |
1992-10-28 |
Prendergast Kennet F |
Anti-viral peptides
|
|
US6217869B1
(en)
|
1992-06-09 |
2001-04-17 |
Neorx Corporation |
Pretargeting methods and compounds
|
|
GB9223084D0
(en)
|
1992-11-04 |
1992-12-16 |
Imp Cancer Res Tech |
Compounds to target cells
|
|
EP0602290B1
(en)
|
1992-12-04 |
1999-08-25 |
ConjuChem, Inc. |
Antibody-conjugated Hepatitis B surface antigen and use thereof
|
|
US6090925A
(en)
|
1993-03-09 |
2000-07-18 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
|
WO1995006737A1
(en)
*
|
1993-09-03 |
1995-03-09 |
Kenneth Francis Prendergast |
Glycophorin binding protein (gbp130) fusion compositions
|
|
US6153203A
(en)
|
1993-10-08 |
2000-11-28 |
Duotol Ab |
Immunological tolerance-inducing agent
|
|
US5681571A
(en)
|
1993-10-08 |
1997-10-28 |
Duotol Ab |
Immunological tolerance-inducing agent
|
|
CA2183535A1
(en)
|
1994-02-28 |
1995-08-31 |
Ronald P. Taylor |
Antigen-based heteropolymers and method for treating autoimmune diseases using the same
|
|
US5698679A
(en)
|
1994-09-19 |
1997-12-16 |
National Jewish Center For Immunology And Respiratory Medicine |
Product and process for targeting an immune response
|
|
US5718915A
(en)
|
1994-10-31 |
1998-02-17 |
Burstein Laboratories, Inc. |
Antiviral liposome having coupled target-binding moiety and hydrolytic enzyme
|
|
US5997861A
(en)
|
1994-10-31 |
1999-12-07 |
Burstein Laboratories, Inc. |
Antiviral supramolecules containing target-binding molecules and therapeutic molecules bound to spectrin
|
|
US5886143A
(en)
|
1994-12-07 |
1999-03-23 |
Neorx Corporation |
Hepatic-directed compounds and reagents for preparation thereof
|
|
US20040258688A1
(en)
|
1995-01-31 |
2004-12-23 |
Daniel Hawiger |
Enhanced antigen delivery and modulation of the immune response therefrom
|
|
US20020187131A1
(en)
|
1995-01-31 |
2002-12-12 |
Daniel Hawiger |
Enhanced antigen delivery and modulation of the immune response therefrom
|
|
AU716056B2
(en)
|
1995-01-31 |
2000-02-17 |
Rockefeller University, The |
Identification of DEC, (dentritic and epithelial cells, 205 kDa), a receptor with C-type lectin domains, nucleic acids encoding DEC, and uses thereof
|
|
EP0837696B1
(en)
|
1995-06-07 |
2010-02-24 |
Immunomedics, Inc. |
Improved delivery of diagnostic and therapeutic agents to a target site
|
|
US6512103B1
(en)
|
1995-12-08 |
2003-01-28 |
Schering Corporation |
Mammalian chemokine reagents
|
|
US6060054A
(en)
|
1996-04-10 |
2000-05-09 |
National Jewish Medical And Research Center |
Product for T lymphocyte immunosuppression
|
|
US6124128A
(en)
|
1996-08-16 |
2000-09-26 |
The Regents Of The University Of California |
Long wavelength engineered fluorescent proteins
|
|
CA2267930A1
(en)
|
1996-10-09 |
1998-04-16 |
Nobuyuki Takechi |
A method for producing a microparticle
|
|
US5994104A
(en)
|
1996-11-08 |
1999-11-30 |
Royal Free Hospital School Of Medicine |
Interleukin-12 fusion protein
|
|
US20090280132A1
(en)
|
1997-01-07 |
2009-11-12 |
Habib Zaghouani |
Coupling of peripheral tolerance to endogenous il-10 promotes effective modulation of t cells and ameliorates autoimmune disease
|
|
US20020081298A1
(en)
|
1997-01-07 |
2002-06-27 |
Habib Zaghouani |
Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors
|
|
US20030103967A1
(en)
|
1997-01-07 |
2003-06-05 |
Habib Zaghouani |
Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors
|
|
US20070218053A1
(en)
|
1997-01-07 |
2007-09-20 |
Habib Zaghouani |
Coupling of peripheral tolerance to endogenous il-10 promotes effective modulation of t cells and ameliorates autoimmune disease
|
|
US6737057B1
(en)
|
1997-01-07 |
2004-05-18 |
The University Of Tennessee Research Corporation |
Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors
|
|
US5948639A
(en)
|
1997-04-10 |
1999-09-07 |
Millennium Pharmaceuticals, Inc. |
TGF-β pathway genes
|
|
JP2001515360A
(ja)
|
1997-04-18 |
2001-09-18 |
バイオジェン，インコーポレイテッド |
▲ＩＩ▼型ＴＧＦ−βレセプター／免疫グロブリン定常領域融合タンパク質
|
|
CU22737A1
(es)
*
|
1997-04-28 |
2002-02-28 |
Ct Ingenieria Genetica Biotech |
Proteínas de fusión recombinantes basadas en adhesinas bacterianas para el desarrollo de ensayos diagnóstico
|
|
US6120770A
(en)
*
|
1997-09-12 |
2000-09-19 |
University Of Notre Dame Du Lac |
Plasmodium proteins useful for preparing vaccine compositions
|
|
US6953675B2
(en)
|
1997-11-06 |
2005-10-11 |
Immunomedics, Inc. |
Landscaped antibodies and antibody fragments for clinical use
|
|
US6703488B1
(en)
|
1998-01-15 |
2004-03-09 |
Center For Molecular Medicine And Immunology |
Antibody/receptor targeting moiety for enhanced delivery of armed ligand
|
|
ES2322975T3
(es)
|
1998-01-15 |
2009-07-02 |
Center For Molecular Medicine And Immunology |
Componente direccionador biespecifico que comprende un anticuerpo contra el antigeno carcinoembrionario (cea) y la region de union a ligando de la subunidad alfa del receptor de il-13.
|
|
ATE262926T1
(de)
*
|
1998-01-29 |
2004-04-15 |
Poly Med Inc |
Asorbierbare mikropartikel
|
|
US6562347B1
(en)
|
1998-03-12 |
2003-05-13 |
The United States Of America As Represented By The Department Of Health And Human Services |
Chemokine-tumor antigen fusion proteins as cancer vaccines
|
|
US6224794B1
(en)
|
1998-05-06 |
2001-05-01 |
Angiotech Pharmaceuticals, Inc. |
Methods for microsphere production
|
|
US7041287B2
(en)
|
1998-05-21 |
2006-05-09 |
Trustees Of The University Of Pennsylvania |
Compositions and methods for selective dissolution of nascent intravascular blood clots
|
|
EP1093378A4
(en)
|
1998-05-21 |
2001-10-10 |
Univ Pennsylvania |
COMPOSITIONS AND TECHNIQUES FOR PREVENTING AND TREATING ANARCHIC FORMATION OF INTRAVASCULAR FIBRINOUS CLOTS
|
|
CA2330939A1
(en)
|
1998-06-16 |
1999-12-23 |
Biogen, Inc. |
Variant type ii tgf-beta receptor fusion proteins and methods
|
|
AU5090899A
(en)
|
1998-07-06 |
2000-01-24 |
University Of Tennessee Research Corporation, The |
Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors
|
|
JP3762222B2
(ja)
|
1998-10-07 |
2006-04-05 |
ストライカー・コーポレーション |
改変型ＴＧＦ−βスーパーファミリータンパク質
|
|
EP1046651A1
(en)
|
1999-04-19 |
2000-10-25 |
Koninklijke Universiteit Nijmegen |
Composition and method for modulating dendritic cell-T interaction
|
|
FR2794461B1
(fr)
|
1999-06-07 |
2004-01-23 |
Lab Francais Du Fractionnement |
Procede de preparation de nouvelles fractions d'ig humaines possedant une activite immunomodulatrice
|
|
WO2001022995A1
(en)
|
1999-09-30 |
2001-04-05 |
Novo Nordisk A/S |
A method for preparing conjugates between an antigen and mucosal binding component
|
|
GB9923306D0
(en)
|
1999-10-01 |
1999-12-08 |
Isis Innovation |
Diagnostic and therapeutic epitope, and transgenic plant
|
|
EP2206720A1
(en)
|
2000-04-12 |
2010-07-14 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
|
EP1292621B1
(en)
|
2000-06-05 |
2006-09-20 |
University of Tennessee Corporation |
Compositions for treating autoimmune disease
|
|
CA2414272A1
(en)
|
2000-07-10 |
2002-01-17 |
Novartis Ag |
Bifunctional molecules and vectors complexed therewith for targeted gene delivery
|
|
US20020127241A1
(en)
*
|
2000-08-07 |
2002-09-12 |
Narum David L. |
Anti-plasmodium compositions and methods of use
|
|
GB0019302D0
(en)
|
2000-08-08 |
2000-09-27 |
Univ Nottingham Trent |
Biological materials and the use thereof for the treatment of disease
|
|
SE0003538D0
(sv)
|
2000-09-29 |
2000-09-29 |
Isconova Ab |
New immunogenic complex
|
|
EP1355965B1
(en)
|
2000-10-19 |
2012-09-19 |
Ecole Polytechnique Fédérale de Lausanne (EPFL) |
Method of synthesizing block copolymers for multifunctional self-assembled systems
|
|
US7470420B2
(en)
|
2000-12-05 |
2008-12-30 |
The Regents Of The University Of California |
Optical determination of glucose utilizing boronic acid adducts
|
|
US7175988B2
(en)
|
2001-02-09 |
2007-02-13 |
Human Genome Sciences, Inc. |
Human G-protein Chemokine Receptor (CCR5) HDGNR10
|
|
CN1312181C
(zh)
|
2001-02-12 |
2007-04-25 |
米德列斯公司 |
抗Fcα受体(CD89)的人单克隆抗体
|
|
EP1241249A1
(en)
*
|
2001-03-12 |
2002-09-18 |
Gerold Schuler |
CD4+CD25+regulatory T cells from human blood
|
|
ATE493186T1
(de)
|
2001-04-10 |
2011-01-15 |
Bioe Llc |
Zelltrennungszusammensetzungen und -verfahren
|
|
US7265208B2
(en)
*
|
2001-05-01 |
2007-09-04 |
The Regents Of The University Of California |
Fusion molecules and treatment of IgE-mediated allergic diseases
|
|
US7328453B2
(en)
|
2001-05-09 |
2008-02-05 |
Ecd Systems, Inc. |
Systems and methods for the prevention of unauthorized use and manipulation of digital content
|
|
GB0113798D0
(en)
|
2001-06-06 |
2001-07-25 |
Chiron Spa |
Antigens and vectors for vaccination
|
|
CA2489019A1
(en)
|
2001-06-15 |
2002-12-27 |
Nordic Vaccine Technology A/S |
Therapeutical vaccination
|
|
ATE512982T1
(de)
|
2001-08-17 |
2011-07-15 |
Exothera L L C |
Verfahren und zusammensetzung zum gezielten einbringen in exosome
|
|
FR2829500B1
(fr)
|
2001-09-13 |
2003-12-12 |
Hemosystem |
Procede de concentration et de detection de germes pathogenes a partir de produits sanguins et/ou de leurs derives et dispositif pour le mettre en oeuvre
|
|
EP1443963B1
(en)
|
2001-10-22 |
2014-05-21 |
The Scripps Research Institute |
Antibody targeting compounds
|
|
EP1440090A2
(en)
|
2001-10-23 |
2004-07-28 |
Centre for Translational Research in Cancer |
A synthetic chimeric fusion protein with immuno-therapeutic uses
|
|
US20030211078A1
(en)
|
2001-12-07 |
2003-11-13 |
Heavner George A. |
Pseudo-antibody constructs
|
|
GB0202399D0
(en)
|
2002-02-01 |
2002-03-20 |
Univ Bristol |
Peptide
|
|
AU2003216184A1
(en)
|
2002-02-05 |
2003-09-02 |
The Regents Of The University Of California |
Nucleic acid molecules encoding cd1-derived endosomal targeting proteins and uses thereof
|
|
GB0212885D0
(en)
|
2002-06-05 |
2002-07-17 |
Isis Innovation |
Therapeutic epitopes and uses thereof
|
|
ES2300652T3
(es)
|
2002-08-06 |
2008-06-16 |
Loma Linda University |
Sustancias para prevenir y tratar enfermedades autoinmunes.
|
|
US20040146948A1
(en)
|
2002-10-18 |
2004-07-29 |
Centenary Institute Of Cancer Medicine And Cell Biology |
Compositions and methods for targeting antigen-presenting cells with antibody single-chain variable region fragments
|
|
EP2292259A3
(en)
*
|
2002-11-15 |
2011-03-23 |
MUSC Foundation For Research Development |
Complement receptor 2 targeted complement modulators
|
|
WO2004060910A2
(en)
|
2002-12-16 |
2004-07-22 |
Wayne State University |
Bioactive peptides and unique ires elements from myelin proteolipid protein plp/dm20
|
|
US20050281828A1
(en)
|
2003-03-04 |
2005-12-22 |
Bowdish Katherine S |
Method of treating autoimmune disease by inducing antigen presentation by tolerance inducing antigen presenting cells
|
|
JP2006521387A
(ja)
|
2003-03-04 |
2006-09-21 |
アレクシオン ファーマシューティカルズ， インコーポレイテッド |
寛容誘導抗原提示細胞による抗原提示の誘導によって自己免疫疾患を治療する方法
|
|
US20070059794A1
(en)
|
2003-04-28 |
2007-03-15 |
Sekisui Chemical Company Limited |
Chaperonin-target protein complex, method of producing the same, method of stabilizing target protein, method of immobilizing target protein, method of analyzing the structure of target protein, sustained-release formulation, and method of producing antibody against target protein
|
|
AU2003232751A1
(en)
|
2003-05-12 |
2004-11-26 |
Tolerogen, Ltd. |
Immunoglobulin conjugates of autoantigens and their use in the prevention of disease
|
|
US8007805B2
(en)
|
2003-08-08 |
2011-08-30 |
Paladin Labs, Inc. |
Chimeric antigens for breaking host tolerance to foreign antigens
|
|
US8198020B2
(en)
|
2003-08-22 |
2012-06-12 |
Potentia Pharmaceuticals, Inc. |
Compositions and methods for enhancing phagocytosis or phagocyte activity
|
|
US20050100964A1
(en)
*
|
2003-11-11 |
2005-05-12 |
George Jackowski |
Diagnostic methods for congestive heart failure
|
|
WO2005051174A2
(en)
|
2003-11-21 |
2005-06-09 |
The Trustees Of Columbia University In The City Of New York |
Nucleic acid aptamer-based compositions and methods
|
|
US20110064754A1
(en)
|
2005-03-03 |
2011-03-17 |
Center For Molecular Medicine And Immunology |
Immunoconjugates Comprising Poxvirus-Derived Peptides and Antibodies Against Antigen-Presenting Cells for Subunit-Based Poxvirus Vaccines
|
|
FR2869323B1
(fr)
*
|
2004-04-22 |
2006-07-21 |
Univ Reims Champagne Ardenne |
Utilisation du gene codant la chaine beta de la proteine c4bp dans la production de proteines dimeriques recombinantes
|
|
EP2486935B1
(en)
|
2004-04-28 |
2021-04-07 |
BTG International Limited |
Epitopes related to Coeliac Disease
|
|
AU2005258281A1
(en)
|
2004-06-24 |
2006-01-05 |
The Scripps Research Institute |
Arrays with cleavable linkers
|
|
WO2006093524A2
(en)
|
2004-07-16 |
2006-09-08 |
The General Hospital Corporation |
Antigen-carbohydrate conjugates
|
|
EP1778296B1
(en)
*
|
2004-07-20 |
2012-06-06 |
Isogenis, Inc. |
Specific inhibition of autoimmunity and diseases associated with autoantigens
|
|
FR2873925B1
(fr)
|
2004-08-05 |
2006-10-13 |
Erytech Pharma Soc Par Actions |
Procede et dispositif de lyse-rescellement pour l'incorporation de principe actif notamment asparaginase ou inositol hexaphosphate, dans des erythrocytes
|
|
TW200616604A
(en)
|
2004-08-26 |
2006-06-01 |
Nicholas Piramal India Ltd |
Nitric oxide releasing prodrugs containing bio-cleavable linker
|
|
WO2006034081A2
(en)
|
2004-09-17 |
2006-03-30 |
Massachusetts Institute Of Technology |
Polymers for analyte detection
|
|
EP1850832B1
(en)
|
2005-02-07 |
2014-12-31 |
Lipotek PTY Ltd |
Adjuvanting material
|
|
ES2665422T3
(es)
|
2005-03-03 |
2018-04-25 |
Immunomedics Inc. |
Anticuerpos L243 humanizados
|
|
FR2884717B1
(fr)
|
2005-04-25 |
2009-07-03 |
Erytech Pharma Soc Par Actions |
Erythrocytes renfermant de l'arginine deiminase
|
|
EP1891141B1
(en)
|
2005-05-31 |
2016-11-16 |
Ecole Polytechnique Fédérale de Lausanne (EPFL) |
Triblock copolymers for cytoplasmic delivery of gene-based drugs
|
|
US7811809B2
(en)
|
2005-06-15 |
2010-10-12 |
Saint Louis University |
Molecular biosensors for use in competition assays
|
|
SI1904104T1
(sl)
|
2005-07-08 |
2013-12-31 |
Biogen Idec Ma Inc. |
Protitelesa SP35 in njihova uporaba
|
|
FI20050814A0
(fi)
|
2005-08-11 |
2005-08-11 |
Procollagen Oy |
Menetelmä nivelreumassa muodostuvien kollageeniautovasta-aineiden havaitsemiseksi
|
|
WO2008039206A2
(en)
|
2005-10-05 |
2008-04-03 |
The Trustees Of The University Of Pennsylvania |
Fusion proteins for inhibition and dissolution of coagulation
|
|
WO2007061936A2
(en)
|
2005-11-18 |
2007-05-31 |
New England Medical Center Hospitals, Inc. |
Clearance of abnormal iga1 in iga1 deposition diseases
|
|
WO2007097934A2
(en)
|
2006-02-17 |
2007-08-30 |
Elusys Therapeutics, Inc. |
Methods and compositions for using erythrocytes as carriers for delivery of drugs
|
|
US8021689B2
(en)
|
2006-02-21 |
2011-09-20 |
Ecole Polytechnique Federale de Lausanne (“EPFL”) |
Nanoparticles for immunotherapy
|
|
US7420040B2
(en)
|
2006-02-24 |
2008-09-02 |
Arius Research Inc. |
Cytotoxicity mediation of cells evidencing surface expression of TROP-2
|
|
US20080131428A1
(en)
|
2006-02-24 |
2008-06-05 |
Arius Research, Inc. |
Cytotoxicity mediation of cells evidencing surface expression of TROP-2
|
|
US20080213267A1
(en)
|
2006-02-24 |
2008-09-04 |
Arius Research, Inc. |
Cytotoxicity mediation of cells evidencing surface expression of TROP-2
|
|
US20080305104A1
(en)
|
2006-02-24 |
2008-12-11 |
Young David S F |
Cytotoxicity mediation of cells evidencing surface expression of TROP-2
|
|
WO2007099387A1
(en)
|
2006-03-03 |
2007-09-07 |
Mymetics Corporation |
Virosome-like vesicles comprising gp41-derived antigens
|
|
CN101443351A
(zh)
*
|
2006-03-09 |
2009-05-27 |
阿普拉根有限公司 |
修饰的促进血细胞生成的分子
|
|
US20090238883A1
(en)
|
2006-04-28 |
2009-09-24 |
Kren Betsy T |
Liver-specific nanocapsules and methods of using
|
|
WO2007150020A1
(en)
|
2006-06-23 |
2007-12-27 |
Simon Paul M |
Targeted immune conjugates
|
|
JP2010505883A
(ja)
|
2006-10-12 |
2010-02-25 |
ザ ユニバーシティー オブ クイーンズランド |
免疫応答を調節するための組成物および方法
|
|
WO2008130382A2
(en)
|
2006-10-31 |
2008-10-30 |
East Carolina University |
Fusion proteins comprising an anti -inflammatory cytokine and an antigen for treatment of immune disorders
|
|
CA2667802A1
(en)
|
2006-11-03 |
2008-05-29 |
Northwestern University |
Multiple sclerosis therapy
|
|
US9457047B2
(en)
|
2006-11-06 |
2016-10-04 |
Whitehead Institute |
Immunomodulating compositions and methods of use thereof
|
|
JP6082174B2
(ja)
|
2006-11-06 |
2017-02-15 |
ホワイトヘッド・インスティテュート・フォー・バイオメディカル・リサーチ |
免疫調節組成物及びその使用方法
|
|
EP1938836A1
(en)
|
2006-12-28 |
2008-07-02 |
Universite Rene Descartes (Paris V) |
Compositions comprising a B subunit of shiga toxin and a means stimulating NKT cells
|
|
US7786267B2
(en)
|
2007-02-02 |
2010-08-31 |
Baylor Research Institute |
Multivariable antigens complexed with targeting humanized monoclonal antibody
|
|
KR20090114430A
(ko)
|
2007-02-02 |
2009-11-03 |
베일러 리서치 인스티튜트 |
항원-제시 세포 상에서 발현된 ｄｃｉｒ에 대한 항원 표적화에 기초한 백신
|
|
TWI422594B
(zh)
|
2007-02-02 |
2014-01-11 |
Baylor Res Inst |
經由樹狀細胞去唾液酸糖蛋白受體（ｄｃ-ａｓｇｐｒ）接合抗原呈現細胞之藥劑
|
|
TW200846363A
(en)
|
2007-03-22 |
2008-12-01 |
Urrma R & B |
Novel human anti-R7V antibodies and uses thereof
|
|
DK2160401T3
(da)
|
2007-05-11 |
2014-10-20 |
Altor Bioscience Corp |
Fusionsmolekyler og il-15-varianter
|
|
US8889140B2
(en)
|
2007-05-31 |
2014-11-18 |
Transtarget, Inc. |
Compositions and methods for tissue repair
|
|
US7507539B2
(en)
|
2007-07-30 |
2009-03-24 |
Quest Diagnostics Investments Incorporated |
Substractive single label comparative hybridization
|
|
RU2010107199A
(ru)
|
2007-07-31 |
2011-09-10 |
Дзе Джонс Хопкинс Юниверсити (Us) |
Конъюгат полипептид-нуклеиновая кислота для иммунопрофилактики или иммунотерапии для неопластических или инфекционных нарушений
|
|
FR2919804B1
(fr)
|
2007-08-08 |
2010-08-27 |
Erytech Pharma |
Composition et vaccin therapeutique anti-tumoral
|
|
EP2192924B1
(en)
|
2007-08-20 |
2017-10-11 |
Protalix Ltd. |
Saccharide-containing protein conjugates and uses thereof
|
|
EP2630966B1
(en)
|
2007-10-12 |
2017-04-19 |
Massachusetts Institute of Technology |
Vaccine nanotechnology
|
|
US9260692B2
(en)
|
2007-10-31 |
2016-02-16 |
Universitat Zurich |
Use of modified cells for the treatment of multiple sclerosis
|
|
EP2057998A1
(en)
*
|
2007-10-31 |
2009-05-13 |
Universitätsklinikum Hamburg-Eppendorf |
Use of modified cells for the treatment of multiple sclerosis
|
|
CN101945666A
(zh)
|
2007-12-19 |
2011-01-12 |
Mivac发展股份公司 |
治疗自身免疫和过敏性疾病的组合物及方法
|
|
FR2925339B1
(fr)
|
2007-12-24 |
2010-03-05 |
Erytech Pharma |
Medicament pour le traitement du cancer du pancreas
|
|
US8333973B2
(en)
|
2008-01-02 |
2012-12-18 |
The Trustees Of The University Of Pennsylvania |
Targeting recombinant therapeutics to circulating red blood cells
|
|
US20100316620A1
(en)
|
2008-02-13 |
2010-12-16 |
Vanessa Bourgeaux |
Formulation and Method for the Prevention and Treatment of Skeletal Manifestation of Gaucher's Disease
|
|
FR2928270B1
(fr)
|
2008-03-10 |
2011-01-21 |
Erytech Pharma |
Formulation methode pour la prevention ou le traitement des metastases osseuses et autres maladies de l'os
|
|
KR101694405B1
(ko)
|
2008-03-28 |
2017-01-23 |
더 리젠츠 오브 더 유니버시티 오브 캘리포니아 |
폴리펩티드―중합체 접합체 및 그의 사용 방법
|
|
AU2009227935B2
(en)
|
2008-03-28 |
2015-07-09 |
Mdna Life Sciences Inc. |
Aberrant mitochondrial DNA, associated fusion transcripts and hybridization probes therefor
|
|
EP2283358B1
(en)
|
2008-04-29 |
2015-04-22 |
Immunexcite, Inc. |
Immunomodulating compositions and methods of use thereof
|
|
US8852640B2
(en)
|
2008-07-03 |
2014-10-07 |
Ecole Polytechnique Federale De Lausanne (Epfl) |
Micelles for delivery of nitric oxide
|
|
DK2982695T3
(da)
|
2008-07-09 |
2019-05-13 |
Biogen Ma Inc |
Sammensætninger, der omfatter antistoffer mod lingo eller fragmenter deraf
|
|
AU2010222928B2
(en)
|
2008-07-16 |
2012-11-29 |
Baylor Research Institute |
Antigen presenting cell targeted vaccines
|
|
US8323696B2
(en)
|
2008-08-29 |
2012-12-04 |
Ecole Polytechnique Federale De Lausanne |
Nanoparticles for immunotherapy
|
|
US8343498B2
(en)
|
2008-10-12 |
2013-01-01 |
Massachusetts Institute Of Technology |
Adjuvant incorporation in immunonanotherapeutics
|
|
US8591905B2
(en)
|
2008-10-12 |
2013-11-26 |
The Brigham And Women's Hospital, Inc. |
Nicotine immunonanotherapeutics
|
|
US8277812B2
(en)
|
2008-10-12 |
2012-10-02 |
Massachusetts Institute Of Technology |
Immunonanotherapeutics that provide IgG humoral response without T-cell antigen
|
|
US8343497B2
(en)
|
2008-10-12 |
2013-01-01 |
The Brigham And Women's Hospital, Inc. |
Targeting of antigen presenting cells with immunonanotherapeutics
|
|
CN101750244B
(zh)
*
|
2008-10-13 |
2014-03-12 |
艾博生物医药(杭州)有限公司 |
一种分离血液样本中红细胞的方法以及运用
|
|
WO2010045518A1
(en)
|
2008-10-16 |
2010-04-22 |
The Trustees Of The University Of Pennsylvania |
Compositions containing thrombomodulin domains and uses thereof
|
|
FR2938332B1
(fr)
|
2008-11-07 |
2011-11-25 |
Erytech Pharma |
Test predictif de la neutralisation de l'activite asparaginase
|
|
US8268977B2
(en)
|
2008-11-20 |
2012-09-18 |
The Board Of Trustees Of The Leland Stanford Junior University |
Strongly quenching oligomeric excimer/quencher pairs for detection schemes
|
|
CN102438643B
(zh)
|
2008-11-30 |
2015-07-01 |
免疫桑特公司 |
用于治疗乳糜泻的组合物和方法
|
|
FR2940087B1
(fr)
|
2008-12-18 |
2011-05-06 |
Lab Francais Du Fractionnement |
Erythrocytes contenant du facteur viii, preparation et utilisations.
|
|
WO2010085509A1
(en)
|
2009-01-20 |
2010-07-29 |
Northwestern University |
Compositions and methods for induction of antigen-specific tolerance
|
|
DK2406286T3
(en)
|
2009-03-10 |
2016-08-22 |
Baylor Res Inst |
Anti-cd40 antibodies and uses thereof
|
|
EP2406289B1
(en)
|
2009-03-10 |
2017-02-22 |
Baylor Research Institute |
Antigen presenting cell targeted anti-viral vaccines
|
|
CA2755686A1
(en)
|
2009-03-16 |
2010-09-23 |
Daniel A. Vallera |
Methods and compositions for bi-specific targeting of cd19/cd22
|
|
FR2944106B1
(fr)
|
2009-04-03 |
2012-09-28 |
Erytech Pharma |
Methode de dosage de l'inositol hexaphosphate (ihp).
|
|
CN102573913B
(zh)
|
2009-07-31 |
2014-06-18 |
阿森迪斯药物股份有限公司 |
可生物降解的基于聚乙二醇的水不溶性水凝胶
|
|
WO2011026122A2
(en)
|
2009-08-31 |
2011-03-03 |
Amplimmune, Inc. |
B7-h4 fusion proteins and methods of use thereof
|
|
US8734786B2
(en)
|
2009-09-16 |
2014-05-27 |
Northwestern University |
Use of ECDI-fixed cell tolerance as a method for preventing allograft rejection
|
|
GB0916749D0
(en)
|
2009-09-23 |
2009-11-04 |
Mologic Ltd |
Peptide cleaning agents
|
|
US20110091493A1
(en)
|
2009-10-16 |
2011-04-21 |
Northwestern University |
Vaccine compositions and uses thereof
|
|
HRP20161223T1
(hr)
|
2009-10-27 |
2016-11-18 |
Erytech Pharma |
Pripravak za induciranje specifične imune tolerancije
|
|
WO2011072290A2
(en)
|
2009-12-11 |
2011-06-16 |
The Regents Of The University Of Michigan |
Targeted dendrimer-drug conjugates
|
|
EP2523686A2
(en)
|
2010-01-14 |
2012-11-21 |
Glaxo Group Limited |
Liver targeting domain antibodies
|
|
US9096655B2
(en)
|
2010-01-27 |
2015-08-04 |
Tata Memorial Centre |
Method for in-vivo binding of chromatin fragments
|
|
US8592364B2
(en)
|
2010-02-11 |
2013-11-26 |
Ecole Polytechnique Federale de Lausanne (“EPFL”) |
CCR7 ligand delivery and co-delivery in immunotherapy
|
|
JP5944836B2
(ja)
|
2010-03-08 |
2016-07-05 |
ユニバーシティ・オブ・ユタ・リサーチ・ファウンデイション |
高分子薬物送達結合体ならびにその製造および使用方法
|
|
IT1399590B1
(it)
|
2010-04-26 |
2013-04-26 |
Erydel Spa |
Apparato e kit per incapsulare almeno un composto ad uso terapeutico e/o diagnostico all'interno di eritrociti
|
|
DK2563753T6
(en)
|
2010-04-27 |
2016-04-04 |
Synaffix Bv |
Fused cyclooctynforbindelser and their use in metal-free click-reactions
|
|
US20130115230A1
(en)
|
2010-04-30 |
2013-05-09 |
Augmenta Biologicals, Llc |
Delivery proteins
|
|
US9326939B2
(en)
|
2010-07-31 |
2016-05-03 |
The Scripps Research Institute |
Liposome targeting compounds and related uses
|
|
EP2598120B1
(en)
|
2010-07-31 |
2018-09-05 |
The Scripps Research Institute |
Compositions and methods for inducing immune tolerance
|
|
US9850296B2
(en)
*
|
2010-08-10 |
2017-12-26 |
Ecole Polytechnique Federale De Lausanne (Epfl) |
Erythrocyte-binding therapeutics
|
|
WO2012021512A2
(en)
*
|
2010-08-10 |
2012-02-16 |
Ecole Polytechnique Federale De Lausanne |
Erythrocyte-binding therapeutics
|
|
US9517257B2
(en)
*
|
2010-08-10 |
2016-12-13 |
Ecole Polytechnique Federale De Lausanne (Epfl) |
Erythrocyte-binding therapeutics
|
|
EP2627665B1
(en)
|
2010-10-12 |
2015-12-16 |
The Children's Hospital Of Philadelphia |
Methods and compositions for treating hemophilia B
|
|
US20120121592A1
(en)
|
2010-10-13 |
2012-05-17 |
Baylor Research Institute |
Targeting Antigens to Human Dendritic Cells Via DC-Asialoglycoprotein Receptor to Produce IL-10 Regulatory T-Cells
|
|
SE535625C2
(sv)
|
2010-10-28 |
2012-10-16 |
Toleranzia Ab |
Nya kompositioner och förfaranden för behandling av autoimmuna och allergiska sjukdomar
|
|
US8501930B2
(en)
|
2010-12-17 |
2013-08-06 |
Arrowhead Madison Inc. |
Peptide-based in vivo siRNA delivery system
|
|
WO2012112690A2
(en)
|
2011-02-16 |
2012-08-23 |
Fabius Biotechnology |
Targeting of therapeutic drugs and diagnostic agents employing collagen binding domains
|
|
WO2012167088A1
(en)
|
2011-06-03 |
2012-12-06 |
3M Innovative Properties Company |
Heterobifunctional linkers with polyethylene glycol segments and immune response modifier conjugates made therefrom
|
|
EP2811831B1
(en)
|
2012-02-07 |
2018-04-11 |
The Regents Of The University Of California |
Glycosphingolipids for use in modulating immune responses
|
|
SG10201609500QA
(en)
|
2012-02-15 |
2016-12-29 |
Ecole Polytech |
Erythrocyte-binding therapeutics
|
|
AU2013245645A1
(en)
|
2012-04-13 |
2014-11-13 |
Whitehead Institute For Biomedical Research |
Sortase- modified VHH domains and uses thereof
|
|
WO2013160865A1
(en)
|
2012-04-26 |
2013-10-31 |
Toleranzia Ab |
Immunotolerizing fusion proteins for treatment of multiple sclerosis
|
|
WO2014011465A2
(en)
|
2012-07-13 |
2014-01-16 |
Albert Einstein College Of Medicine Of Yeshiva University |
Aptamer-targeted antigen delivery
|
|
EP2882775B1
(en)
|
2012-08-09 |
2018-02-14 |
Roche Glycart AG |
Asgpr antibodies and uses thereof
|
|
WO2014052545A2
(en)
|
2012-09-28 |
2014-04-03 |
Dana-Farber Cancer Institute, Inc. |
Targeted expansion of qa-1-peptide-specific regulatory cd8 t cells to ameliorate arthritis
|
|
US9371352B2
(en)
|
2013-02-08 |
2016-06-21 |
Vaccinex, Inc. |
Modified glycolipids and methods of making and using the same
|
|
WO2014135528A1
(en)
|
2013-03-04 |
2014-09-12 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Fusion proteins and immunoconjugates and uses thereof
|
|
BR112015026019A2
(pt)
|
2013-04-11 |
2017-07-25 |
Brigham & Womens Hospital Inc |
métodos e composições de tratamento de doenças autoimunes
|
|
EP2989123A4
(en)
|
2013-04-22 |
2016-10-12 |
Scripps Research Inst |
METHODS AND COMPOSITIONS FOR TREATING COAGULATION DISORDERS
|
|
US10946079B2
(en)
|
2014-02-21 |
2021-03-16 |
Ecole Polytechnique Federale De Lausanne |
Glycotargeting therapeutics
|
|
US10953101B2
(en)
|
2014-02-21 |
2021-03-23 |
École Polytechnique Fédérale De Lausanne (Epfl) |
Glycotargeting therapeutics
|
|
US10046056B2
(en)
|
2014-02-21 |
2018-08-14 |
École Polytechnique Fédérale De Lausanne (Epfl) |
Glycotargeting therapeutics
|
|
KR102717969B1
(ko)
|
2014-02-21 |
2024-10-15 |
에꼴 뽈리떼끄닉 뻬데랄 드 로잔느 (으뻬에프엘) |
글리코타겟팅 치료제
|
|
ES2865825T3
(es)
|
2014-04-01 |
2021-10-18 |
Rubius Therapeutics Inc |
Procedimientos y composiciones para inmunomodulación
|
|
LT3129406T
(lt)
|
2014-04-11 |
2019-04-10 |
Medimmune, Llc |
Konjuguoti junginiai, apimantys inžineriniu būdu sukonstruotus cisteino antikūnus
|
|
WO2015171863A1
(en)
|
2014-05-08 |
2015-11-12 |
The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. |
USING B-CELL-TARGETING ANTIGEN IgG FUSION AS TOLEROGENIC PROTEIN THERAPY FOR TREATING ADVERSE IMMUNE RESPONSES
|
|
CN106659774A
(zh)
|
2014-05-16 |
2017-05-10 |
贝勒研究院 |
用于治疗自身免疫和炎性病症的方法和组合物
|
|
US10087257B2
(en)
|
2014-08-08 |
2018-10-02 |
The Board Of Trustees Of The Leland Stanford Junior University |
SIRP alpha-antibody fusion proteins
|
|
US20160060358A1
(en)
|
2014-08-28 |
2016-03-03 |
California Institute Of Technology |
Induction of antigen-specific tolerance
|
|
IL315468A
(en)
|
2014-09-17 |
2024-11-01 |
Spogen Biotech Inc |
Fusion proteins, recombinant bacteria, and methods for using recombinant bacteria
|
|
MA40861A
(fr)
|
2014-10-31 |
2017-09-05 |
Biogen Ma Inc |
Anticorps anti-glycoprotéines iib/iiia
|
|
US20180117171A1
(en)
|
2015-04-01 |
2018-05-03 |
President And Fellows Of Harvard College |
Immunoconjugates for programming or reprogramming of cells
|
|
WO2016183361A1
(en)
|
2015-05-13 |
2016-11-17 |
Advaxis, Inc. |
Immunogenic listeria-based compositions comprising truncated acta-antigen fusions and methods of use thereof
|
|
WO2016210447A1
(en)
|
2015-06-26 |
2016-12-29 |
University Of Southern California |
Masking chimeric antigen receptor t cells for tumor-specific activation
|
|
WO2017015141A1
(en)
|
2015-07-17 |
2017-01-26 |
President And Fellows Of Harvard College |
Humanized anti-glycophorin a antibodies and uses thereof
|
|
EP3328377A4
(en)
|
2015-07-31 |
2019-03-13 |
Tarveda Therapeutics, Inc. |
COMPOSITIONS AND METHODS FOR IMMUNE ONCOLOGY THERAPIES
|
|
WO2017025889A1
(en)
|
2015-08-13 |
2017-02-16 |
Pfizer Inc. |
Polymeric nanoparticles with dec-205 ligand and co-encapsulating an antigen subject to an autoimmune response and a glucocorticoid receptor agonist
|
|
CA2997442C
(en)
|
2015-09-04 |
2021-01-26 |
Yale University |
Polymeric bile acid nanocompositions targeting the pancreas and colon
|
|
WO2017044308A1
(en)
|
2015-09-10 |
2017-03-16 |
Albert Einstein College Of Medicine, Inc. |
Synthetic antibodies to bax and uses thereof
|
|
EP3349784A1
(en)
|
2015-09-19 |
2018-07-25 |
Ecole Polytechnique Fédérale de Lausanne |
Glycotargeting therapeutics
|
|
EP3356371A4
(en)
|
2015-09-29 |
2020-06-24 |
The University of Chicago |
POLYMER CONJUGATE VACCINE
|
|
WO2017066484A2
(en)
|
2015-10-13 |
2017-04-20 |
Carter Daniel C |
Nsp10 self-assembling fusion proteins for vaccines, therapeutics, diagnostics and other nanomaterial applications
|
|
EP3701963A1
(en)
|
2015-12-22 |
2020-09-02 |
CureVac AG |
Method for producing rna molecule compositions
|
|
IL260074B2
(en)
|
2015-12-23 |
2026-01-01 |
Cour Pharmaceuticals Dev Company Inc |
Covalent polymer-antigen particle conjugates
|
|
WO2017139498A1
(en)
|
2016-02-09 |
2017-08-17 |
Cour Pharmaceuticals Development Company Inc. |
Timps encapsulating japanese cedar pollen epitopes
|
|
US20190046620A1
(en)
|
2016-02-12 |
2019-02-14 |
Bloodworks |
Therapeutic induction of tolerance using recombinant cell surface antigens
|
|
WO2017155981A1
(en)
|
2016-03-07 |
2017-09-14 |
Massachusetts Institute Of Technology |
Protein-chaperoned t-cell vaccines
|
|
KR102490952B1
(ko)
|
2016-05-03 |
2023-01-19 |
에스큐지 바이오테크놀로지스 컴퍼니 |
관용을 유도하는 생체분자의 세포내 전달
|
|
JP7602702B2
(ja)
|
2016-05-03 |
2024-12-19 |
ステムセル テクノロジーズ カナダ インコーポレーテッド |
寛容性を誘導するための生体分子の細胞内送達
|
|
US20170326213A1
(en)
|
2016-05-16 |
2017-11-16 |
Augusta University Research Institute, Inc. |
Protein-Coupled Red Blood Cell Compositions and Methods of Their Use
|
|
JP6687498B2
(ja)
|
2016-10-25 |
2020-04-22 |
住友ナコ フォ−クリフト株式会社 |
カメラ用装着ブラケット
|
|
US11253579B2
(en)
|
2017-06-16 |
2022-02-22 |
The University Of Chicago |
Compositions and methods for inducing immune tolerance
|
|
US12116417B2
(en)
|
2017-11-14 |
2024-10-15 |
GC Cell Corporation |
Anti-HER2 antibody or antigen-binding fragment thereof, and chimeric antigen receptor comprising same
|
|
WO2019191079A1
(en)
|
2018-03-26 |
2019-10-03 |
The University Of Chicago |
Methods and compositions for targeting liver and lymph node sinusoidal endothelial cell c-type lectin (lsectin)
|
|
EP3790901A1
(en)
|
2018-05-07 |
2021-03-17 |
Anokion SA |
Glycophorin a antigen-binding proteins
|
|
CN113710229B
(zh)
*
|
2019-02-25 |
2026-01-06 |
芝加哥大学 |
用与抗炎剂连接的ecm亲和肽治疗炎症性和自身免疫性病症的方法和组合物
|